US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NeuroSense Therapeutics Equity Warrant Exp 9th Nov 2026 Warrant

0.2000

0.0000

Volume:- -

Turnover:- -

Market Cap:4.80M

PE:-0.67

High:0.2000

Open:0.2000

Low:0.2000

Close:0.2000

52wk High:1.00

52wk Low:0.1531

Shares:23.99M

Float Shares:23.99M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2972

ROE:-2478.16%

ROA:-303.90%

PB:-9.24

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NeuroSense Therapeutics Equity Warrant Exp 9th Nov 2026 Warrant

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

- -

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRSNW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRSNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSNW\",,,,,undefined,":{"symbol":"NRSNW","market":"US","secType":"STK","nameCN":"NeuroSense Therapeutics Equity Warrant Exp 9th Nov 2026 Warrant","latestPrice":0.2,"timestamp":1771016400000,"preClose":0.2,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":23988668,"shares":23988668,"eps":-0.2972,"marketStatus":"Market Closed","change":0,"latestTime":"02-13 16:00:00 EST","open":0.2,"high":0.2,"low":0.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.2972,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"listingDate":1639026000000,"exchange":"NASDAQ","adjPreClose":0.2,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSNW\",,,,,undefined,":{"symbol":"NRSNW","floatShares":23988668,"roa":"-303.90%","roe":"-2478.16%","lyrEps":0,"shares":23988668,"dividePrice":0,"high":0.2,"amplitude":0,"preClose":0.2,"low":0.2,"week52Low":0.1531,"pbRate":"-9.24","week52High":1,"institutionHeld":0,"latestPrice":0.2,"eps":-0.2972,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.2972,"open":0.2,"prevYearClose":0.3197,"prevWeekClose":0.2131,"prevMonthClose":0.38,"prevQuarterClose":0.3197,"fiveDayClose":0.2131,"twentyDayClose":0.31,"sixtyDayClose":0.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRSNW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRSNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRSNW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":-0.0615},{"period":"1month","weight":-0.3548},{"period":"3month","weight":-0.3099},{"period":"6month","weight":-0.7101},{"period":"1year","weight":-0.3099},{"period":"ytd","weight":-0.3744}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.365357},{"month":2,"riseRate":0.4,"avgChangeRate":0.060307},{"month":3,"riseRate":0.75,"avgChangeRate":0.126087},{"month":4,"riseRate":0.25,"avgChangeRate":-0.093125},{"month":5,"riseRate":0.25,"avgChangeRate":-0.086544},{"month":6,"riseRate":0.75,"avgChangeRate":0.348782},{"month":7,"riseRate":0.25,"avgChangeRate":-0.201466},{"month":8,"riseRate":0.5,"avgChangeRate":-0.076914},{"month":9,"riseRate":0.25,"avgChangeRate":-0.075449},{"month":10,"riseRate":0.25,"avgChangeRate":-0.146685},{"month":11,"riseRate":1,"avgChangeRate":0.597677},{"month":12,"riseRate":0.25,"avgChangeRate":-0.138758}],"exchange":"NASDAQ","name":"NeuroSense Therapeutics Equity Warrant Exp 9th Nov 2026 Warrant","nameEN":"NeuroSense Therapeutics Equity Warrant Exp 9th Nov 2026 Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NRSNW\",market:\"US\",,,undefined,":null}}